Search
Search

| 货号 | 数量 |
|---|---|
| A47015 | 16 Samples |
The Ion Torrent Oncomine Comprehensive Assay Plus GX DNA is a targeted next-generation sequencing (NGS) assay that provides a comprehensive genomic profiling (CGP) solution appropriate for formalin-fixed paraffin-embedded (FFPE) tissues from solid tumors. The assay detects a broad range of genomic alterations from 501 genes, including single-nucleotide variants (SNVs), insertions and deletions (indels), and copy number variations (CNVs) from DNA. Additionally, the assay detects genomic signatures such as homologous recombination deficiency (HRD) using genomic instability metric (GIM), tumor mutational burden (TMB), and microsatellite instability (MSI). This assay is the DNA component of the Oncomine Comprehensive Assay Plus GX (Cat. No. A47013), which includes both DNA and RNA assays.
Key features of the assay include:
When used with the Genexus Purification System and the Genexus Integrated Sequencer, sequential sample purification, library preparation, sequencing, and analysis allow for the reporting of next-day results. With just two user touchpoints and as little as 20 minutes of hands-on time, the easy, automated workflows can help reduce handling errors, free up time for your laboratory staff, and reduce labor costs. As a single vendor of sample-to-report solutions, including instruments, consumables, analysis, and support, Thermo Fisher Scientific simplifies bringing in-house CGP to your lab at varying levels of NGS expertise.